Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600131703) titled 'A Prospective, Multicenter, Single-Arm Objective Performance Criterion Clinical Trial to Evaluate the Efficacy and Safety of the Transcatheter Mitral Valve Repair System' on Sept. 6.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Beijing Anzhen Hospital, Capital Medical University
Condition:
Mitral valve regurgitation
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2022-02-23
Target Sample Size: Experimental Group:118;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341803
Published by HT Digital ...